| Literature DB >> 29843793 |
Chi Chen1, Jia-Lin Dai2.
Abstract
BACKGROUND: Previous studies have revealed that triglyceride to high-density lipoprotein cholesterol (HDL-C) ratio (henceforth TG/HDL-C) is one of major risk factors of cardiovascular diseases, insulin resistance and metabolism syndrome. However, there are fewer scientific dissertations about the correlation between TG/HDL-C and bapWV. This study was undertaken to investigate the relationship between Triglyceride (TG) to high-density lipoprotein cholesterol (HDL-C) ratio and brachial-ankle pulse wave velocity (baPWV) in Japanese.Entities:
Keywords: Association; Brachial-ankle pulse wave velocity; High-density lipoprotein cholesterol; Triglyceride
Mesh:
Substances:
Year: 2018 PMID: 29843793 PMCID: PMC5975424 DOI: 10.1186/s12944-018-0776-7
Source DB: PubMed Journal: Lipids Health Dis ISSN: 1476-511X Impact factor: 3.876
Baseline Characteristics of participants
| TG/HDL-C | Q1 | Q2 | Q3 | Q4 | ||
|---|---|---|---|---|---|---|
| Number | 228 | 228 | 228 | 228 | ||
| AGE (years, mean ± sd) | 50.8 ± 10.0 | 51.8 ± 9.7 | 51.2 ± 9.0 | 50.7 ± 9.6 | 0.638 | 0.600 |
| BMI (kg/m2, mean ± sd) | 21.5 ± 2.4 | 22.6 ± 2.8 | 23.6 ± 3.4 | 24.7 ± 2.9 | < 0.001 | < 0.001 |
| SBP (mmHg, mean ± sd) | 114.1 ± 13.4 | 118.5 ± 15.0 | 123.4 ± 15.1 | 124.9 ± 14.0 | < 0.001 | < 0.001 |
| DBP (mmHg, mean ± sd) | 71.4 ± 9.1 | 74.9 ± 9.8 | 78.3 ± 10.2 | 80.0 ± 8.7 | < 0.001 | < 0.001 |
| AST(IU/L, mean ± sd) | 19.3 ± 6.2 | 19.8 ± 6.0 | 20.9 ± 9.4 | 23.4 ± 9.5 | < 0.001 | < 0.001 |
| ALT(IU/L, mean ± sd) | 16.0 (12.0–20.0) | 17.0 (13.0–23.0) | 20.0 (15.0–28.0) | 24.0 (18.0–35.0) | < 0.001 | < 0.001 |
| GGT (IU/L, mean ± sd) | 14.0(11.0–17.0) | 18.0(14.0–25.2) | 20.0(15.0–33.0) | 24.0 (19.0–41.0) | < 0.001 | < 0.001 |
| Uric acid (mg/dl, mean ± sd) | 4.5 ± 1.2 | 4.9 ± 1.3 | 5.5 ± 1.2 | 6.1 ± 1.2 | < 0.001 | < 0.001 |
| Fasting glucose (mg/dL, mean ± sd) | 93.1 ± 8.3 | 96.2 ± 10.7 | 100.8 ± 20.1 | 102.1 ± 12.4 | < 0.001 | < 0.001 |
| TC (mg/dL, mean ± sd) | 202.7 ± 34.6 | 205.8 ± 34.4 | 210.3 ± 34.7 | 220.6 ± 37.7 | < 0.001 | < 0.001 |
| LDL (mg/dL, mean ± sd) | 115.2 ± 29.2 | 126.7 ± 29.0 | 133.7 ± 29.7 | 136.6 ± 34.4 | < 0.001 | < 0.001 |
| eGFR(mL/min/1.73 m2, mean ± sd) | 73.9 ± 13.2 | 70.8 ± 12.2 | 69.1 ± 10.7 | 67.8 ± 11.1 | < 0.001 | < 0.001 |
| baPWV (cm/s, mean ± sd) | 1344.9 ± 220.6 | 1410.0 ± 231.8 | 1435.0 ± 232.1 | 1473.2 ± 279.9 | < 0.001 | < 0.001 |
| SEX (n,%) | < 0.001 | – | ||||
| Male | 76 (33.3%) | 141 (61.8%) | 173 (75.9%) | 202 (88.6%) | ||
| Female | 152 (66.7%) | 87 (38.2%) | 55 (24.1%) | 26 (11.4%) | ||
| Current smokig (n,%) | < 0.001 | – | ||||
| None | 209 (91.7%) | 181 (79.4%) | 166 (72.8%) | 159 (69.7%) | ||
| Current | 19 (8.3%) | 47 (20.6%) | 62 (27.2%) | 69 (30.3%) | ||
| Ex-Smoking (n,%) | < 0.001 | – | ||||
| No | 162 (71.1%) | 126 (55.3%) | 91 (39.9%) | 82 (36.0%) | ||
| Yes | 66 (28.9%) | 102 (44.7%) | 137 (60.1%) | 146 (64.0%) | ||
| Regular Exercise (> 1 week) (n,%) | 0.003 | – | ||||
| No | 165 (74.3%) | 172 (76.8%) | 187 (82.7%) | 195 (87.1%) | ||
| Yes | 57 (25.7%) | 52 (23.2%) | 39 (17.3%) | 29 (12.9%) | ||
| Fatty liver (n,%) | < 0.001 | – | ||||
| None | 210 (92.1%) | 193 (84.6%) | 141 (62.1%) | 102 (44.7%) | ||
| Yes | 18 (7.9%) | 35 (15.4%) | 86 (37.9%) | 126 (55.3%) | ||
| Post-Menopausal (n,%) | 0.118 | – | ||||
| No | 75 (49.3%) | 33 (37.9%) | 18 (32.7%) | 12 (46.2%) | ||
| Yes | 77 (50.7%) | 54 (62.1%) | 37 (67.3%) | 14 (53.8%) | ||
| Alcohol consumption (n,%) | < 0.001 | – | ||||
| < 40 (g/week) | 174 (76.3%) | 140 (62.2%) | 131 (58.2%) | 136 (61.5%) | ||
| ≤40–140 | 27 (11.8%) | 48 (21.3%) | 36 (16.0%) | 39 (17.6%) | ||
| > 140–280 | 18 (7.9%) | 21 (9.3%) | 27 (12.0%) | 22 (10.0%) | ||
| > 280 | 9 (3.9%) | 16 (7.1%) | 31 (13.8%) | 24 (10.9%) | ||
| ABI | 1.3 ± 0.8 | 1.2 ± 0.1 | 1.2 ± 0.1 | 1.2 ± 0.1 | < 0.001 |
ALT alanine aminotransferase, AST aspartate transaminase, baPWV brachial-ankle pulse wave velocity, BMI body mass index, eGFR estimated glomerular filtration rate, GGT γ-glutamyltranspeptidase, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, SBP systolic pressure, DBP Diastole pressure, Tg triglyceride, TC total cholesterol, ABI ankle-brachial index
The results of univariate analysis
| Statistics | Effect size (β) | ||
|---|---|---|---|
| Sex | |||
| Male | 592 (64.9%) | ref | |
| Female | 320 (35.1%) | −49.4 (−82.8, −16.1) | 0.004 |
| Age | 51.1 ± 9.6 | 12.9 (11.5, 14.4) | < 0.001 |
| BMI | 23.1 ± 3.1 | 5.0 (−0.2, 10.1) | 0.058 |
| SBP | 120.2 ± 15.0 | 8.4 (7.5, 9.4) | < 0.001 |
| DBP | 76.1 ± 10.0 | 11.3 (9.9, 12.7) | < 0.001 |
| AST | 20.9 ± 8.1 | 3.4 (1.4, 5.4) | 0.001 |
| Fasting glucose | 98.1 ± 14.1 | 4.2 (3.1, 5.3) | < 0.001 |
| ALT | 22.7 ± 14.3 | 1.5 (0.4, 2.6) | 0.009 |
| GGT | 25.4 ± 24.4 | 1.0 (0.4, 1.7) | 0.002 |
| Uric acid | 5.3 ± 1.4 | 22.8 (11.3, 34.3) | < 0.001 |
| TC | 209.8 ± 36.0 | 0.7 (0.3, 1.2) | 0.002 |
| Alcohol consumption | |||
| ≤40 (g/week) | 581 (64.6%) | ref | |
| 40–140 | 150 (16.7%) | −7.1 (−51.3, 37.1) | 0.753 |
| 140–280 | 88 (9.8%) | 13.0 (−42.2, 68.1) | 0.645 |
| > 280 | 80 (8.9%) | 50.8 (−6.7, 108.3) | 0.084 |
| LDL-C | 128.1 ± 31.7 | 0.7 (0.2, 1.2) | 0.010 |
| TG/HDL-C | 2.2 ± 2.1 | 14.9 (7.2, 22.5) | < 0.001 |
| Curren Smoking | |||
| None | 715 (78.4%) | ref | |
| Current | 197 (21.6%) | −0.2 (−39.0, 38.7) | 0.994 |
| Ex-Smoking | |||
| None | 461 (50.5%) | ref | |
| Yes | 451 (49.5%) | 25.4 (−6.5, 57.4) | 0.119 |
| Regular Exercise (> 1 week) | |||
| No | 719 (80.2%) | ref | |
| Yes | 177 (19.8%) | 16.7 (−23.2, 56.5) | 0.413 |
| Fatty liver | |||
| No | 646 (70.9%) | ref | |
| Yes | 265 (29.1%) | 93.7 (59.0, 128.5) | < 0.001 |
| eGFR | 70.4 ± 12.0 | −6.4 (−7.6, − 5.1) | < 0.001 |
| ABI | 1.2 ± 0.4 | 30.7 (−8.9, 70.3) | 0.129 |
Relationship between TG/HDL-C and baPWV in different models
| Variable | Crude model (β, 95%CI, P) | Minimally adjusted model(β, 95%CI, P) | Fully adjusted model(β, 95%CI, P) |
|---|---|---|---|
| TG/HDL-C | 14.9 (7.2, 22.5) < 0.001 | 12.7 (5.8, 19.6) < 0.001 | 1.8 (− 5.0, 8.5) 0.609 |
| TG/HDL-C(quartile) | |||
| Q1 | Ref | Ref | Ref |
| Q2 | 65.1 (20.6, 109.6) 0.004 | 41.4 (2.2, 80.5) 0.039 | 28.7 (−5.5, 63.0) 0.101 |
| Q3 | 90.1 (45.6, 134.6) < 0.001 | 69.2 (28.9, 109.6) 0.001 | 14.2 (−23.3, 51.7) 0.459 |
| Q4 | 128.3 (83.9, 172.8) < 0.001 | 108.1 (66.3, 149.9) < 0.001 | 35.1 (−5.2, 75.4) 0.088 |
| P for trend | < 0.001 | < 0.001 | 0.171 |
Crude model: we did not adjust other covariants
Minimally adjusted model: we adjusted age and sex
Fully adjusted model: we adjusted age, sex, BMI, SBP, DBP, AST, ALT, GGT, uric acid, fasting glucose, TC, LDL, eGFR, smoking and exercise status, fatty liver, alcohol consumption, ABI
CI confidence interval, Ref reference
Fig. 1The relationship between TG/HDL-C and baPWV. A nonlinear relationship between them was detected after adjusting for age, sex, BMI, SBP, DBP, AST, ALT, GGT, uric acid, fasting glucose, TC, LDL, eGFR, smoking and exercise status, fatty liver, alcohol consumption and ABI
The results of two-piecewise linear regression model
| Inflection point of TG/HDL-C | Effect size (β) | 95%CI | |
|---|---|---|---|
| < 5.6 | 12.7 | 1.9 to 23.5 | 0.021 |
| ≥5.6 | −16.7 | −36.8 to 3.3 | 0.102 |
Effect: baPWV Cause: TG/HDL-C
Adjusted: age, sex, BMI, SBP, DBP, AST, ALT, GGT, uric acid, fasting glucose, TC, LDL, eGFR, smoking and exercise status, fatty liver, alcohol consumption, ABI
Effect size of TG/HDL-C on baPWV in prespecified and exploratory subgroups
| Characteristic | No of participants | Effect size(95%CI) | P for interaction |
|---|---|---|---|
| Age (year) | 0.85 | ||
| ≤60 | 139 | 6.0 (− 12.3, 24.3) | |
| > 60 | 773 | 4.1 (− 3.8, 12.0) | |
| Sex | 0.69 | ||
| Male | 592 | 3.2 (−4.8, 11.2) | |
| Female | 320 | 7.2 (−11.4, 25.8) | |
| Current smoking | 0.15 | ||
| No | 715 | 7.4 (−1.2, 16.0) | |
| Yes | 197 | −4.0 (−17.1, 9.1) | |
| Ex-Smoking | |||
| No | 462 | 8.6 (−4.0, 21.2) | 0.31 |
| Yes | 450 | 0.8 (−8.1, 9.8) | |
| Regular Exercise (> 1 week) | 0.67 | ||
| No | 719 | 4.6 (−3.3, 12.5) | |
| Yes | 177 | 0.08 (−20.1, 20.2) | |
| Fatty liver | 0.99 | ||
| No | 646 | 7.3 (− 2.4, 17.0) | |
| Yes | 265 | 7.4 (−4.3, 19.1) | |
| Alcohol consumption | 0.01 | ||
| ≤40 (g/week) | 581 | 7.1 (−2.9, 17.0) | |
| 40–140 | 150 | 7.0 (−11.3, 25.3) | |
| 140–280 | 88 | −5.2 (−25.4, 15.0) | |
| > 280 | 80 | −30.7 (−53.1, −8.4) | |
| BMI | 0.50 | ||
| < 18.5 | 36 | 51.9 (−33.8, 137.6) | |
| > = 18.5, < 23 | 435 | 5.2 (−6.5, 16.9) | |
| > = 23 | 441 | 2.8 (−6.5, 12.2) | |
| Hypertension | 0.72 | ||
| No | 790 | 4.4 (−3.6, 12.3) | |
| Yes | 122 | 8.4 (−12.3, 29.0) | |
| Uric acid (tertile) | 0.07 | ||
| Low | 298 | −6.0 (−25.4, 13.3) | |
| Middle | 308 | 14.7 (1.3, 28.1) | |
| High | 306 | −2.8 (−13.0, 7.3) | |
Note 1:Above model adjusted for age, sex, BMI, SBP, DBP, AST, ALT, GGT, uric acid, fasting glucose, TC, LDL, eGFR, smoking and exercise status, fatty liver, alcohol consumption and ABI
Note 2:In each case, the model is not adjusted for the stratification variable
Note 3: a adjusted menopausal status + age, sex, BMI, SBP, DBP, AST, ALT, GGT, uric acid, fasting glucose, TC, LDL, eGFR, smoking and exercise status, fatty liver, alcohol consumption